文献速递癫痫

基于CRISPR的KCC2上调减轻癫痫小鼠模型中的耐药性发作

CRISPR-Based KCC2 Upregulation Attenuates Drug-Resistant Seizure in Mouse Models of Epilepsy.
PubMed 文献 · Ann Neurol · 2023-04-22

研究采用腺相关病毒递送的CRISPRa系统在海马下托特异性上调KCC2,在多种在体癫痫模型中验证其治疗潜力;KCC2上调减轻海马点燃模型发作严重程度并促进地西泮抗发作效应,提高地西泮耐药癫痫持续状态的终止率并拓宽治疗窗,还减轻丙戊酸耐药的自发性发作。

要点

  • 腺相关病毒递送CRISPRa可在下托有效上调KCC2表达。
  • KCC2上调减轻海马点燃模型发作严重程度并促进地西泮抗发作效应。
  • KCC2上调提高地西泮耐药癫痫持续状态终止率并拓宽治疗窗。

核心结论

  • 腺相关病毒介导的CRISPRa递送通过调节与神经元兴奋性直接相关的异常基因表达,具有治疗神经系统疾病的转化潜力,并验证KCC2是治疗耐药性癫痫的有前景靶点。

研究设计与样本

  • 使用腺相关病毒递送的CRISPRa系统在海马下托特异性上调KCC2,在多种在体癫痫模型中验证治疗潜力,并用钙纤维光度法揭示KCC2在恢复受损GABA能抑制中的作用。

主要发现

  • CRISPRa系统在体外细胞培养和体内脑区均有效上调KCC2表达。
  • 腺相关病毒递送CRISPRa上调下托KCC2水平,减轻海马点燃模型中海马发作的严重程度并促进地西泮的抗发作效应。
  • 在海人酸诱导的癫痫持续状态模型中,KCC2上调大幅提高地西泮耐药癫痫持续状态的终止百分比并拓宽治疗窗。
  • KCC2上调减轻海人酸诱导的慢性癫痫模型中丙戊酸耐药的自发性发作。
  • 钙纤维光度法显示CRISPRa介导的KCC2上调部分恢复癫痫中受损的GABAA介导的抑制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The precise intervention of K-Cl cotransporter isoform 2 (KCC2) as a promising target for drug-resistant epilepsy remains elusive. METHODS: Here, we used a CRISPRa system delivered by adeno-associated viruses to specifically upregulate KCC2 in the subiculum to confirm its therapeutic potential in various in vivo epilepsy models. Calcium fiber photometry was used to reveal the role of KCC2 in the restoration of impaired GABAergic inhibition. RESULTS: CRISPRa system effectively upregulated KCC2 expression both in in vitro cell culture and in vivo brain region. Delivery of CRISPRa with adeno-associated viruses resulted in upregulating the subicular KCC2 level, contributing to alleviating the severity of hippocampal seizure and facilitating the anti-seizure effect of diazepam in a hippocampal kindling model. In a kainic acid-induced epilepticus status model, KCC2 upregulation greatly increased the termination percentage of diazepam-resistant epilepticus status with the broadened therapeutic window. More importantly, KCC2 upregulation attenuated valproate-resistant spontaneous seizure in a kainic acid-induced chronic epilepsy model. Finally, calcium fiber photometry showed CRISPRa-mediated KCC2 upregulation partially restored the impaired GABAA -mediated inhibition in epilepsy. INTERPRETATION: These results showed the translational potential of adeno-associated viruses-mediated delivery of CRISPRa for treating neurological disorders by modulating abnormal gene expression that is directly associated with neuronal excitability, validating KCC2 as a promising therapeutic target for treating drug-resistant epilepsy. ANN NEUROL 2023;94:91-105.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Shi J, Xin H, Shao Y, et al. CRISPR-Based KCC2 Upregulation Attenuates Drug-Resistant Seizure in Mouse Models of Epilepsy. Ann Neurol. 2023. PMID: 37014252. doi:10.1002/ana.26656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。